[1] Sauder DN. Biologic properties of epidermal cell thymocyte-activating factor (ETAF). J Invest Dermatol, 1985,85 (1 Suppl):176s-179s. [2] Mizutani H, Black R, Kupper TS. Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J Clin Invest, 1991,87:1066-1071. [3] Kupper TS. Mechanisms of cutaneous inflammation. Interactions between epidermal cytokines, adhesion molecules, and leukocytes.Arch Dermatol, 1989,125:1406-1412. [4] Ansel JC, Luger TA, Lowry D, et al. The expression and modulation of IL-1 alpha in murine keratinocytes. J Immunol, 1988,140:2274-2278. [5] Gilchrest BA, Garmyn M, Yaar M. Aging and photoaging affect gene expression in cultured human keratinocytes. Arch Dermatol, 1994,130:82-86. [6] Ansel J, Perry P, Brown J, et al. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol, 1990,94(6 Suppl):101S-107S. [7] Lee SW, Morhenn VB, Ilnicka M, et al. Autocrine stimulation of interleukin-1 alpha and transforming growth factor alpha production in human keratinocytes and its antagonism by glucocorticoids. J Invest Dermatol, 1991,97:106-110. [8] Kupper TS, McGuire J. Hydrocortisone reduces both constitutive and UV-elicited release of epidermal thymocyte activating factor (ETAF)by cultured keratinocytes. J Invest Dermatol, 1986,87:570-573. |